Australian biotechnology firm Nyrada slides on discounted placement
** Shares of Nyrada NYR.AX slump as much as 16.2% to A$0.310, hitting their lowest level since July 23 ** Stock marks its biggest intraday pct loss since Oct. 2, 2024 ** Biotechnology co raises A$8.25 million via placement at an issue price of A$0.300 per share ** Issue price is at a 18.9% discount to stock's last close ** About 1.5 mln shares traded, 2.8x the 30-day average ** YTD, stock up more than 200% (Reporting by Ananya Verma in Bengaluru) ((ananya.verma@thomsonreuters.com))